Russell Investments Group’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.2K Sell
2,903
-353
-11% -$5.4K ﹤0.01% 3671
2026
Q1
$58K Sell
3,256
-3,194
-50% -$78.4K ﹤0.01% 3275
2025
Q4
$179K Sell
6,450
-419
-6% -$12.1K ﹤0.01% 2881
2025
Q3
$273K Buy
6,869
+3,959
+136% +$161K ﹤0.01% 2694
2025
Q2
$111K Sell
2,910
-1
-0% -$28 ﹤0.01% 2796
2025
Q1
$78K Sell
2,911
-1,306
-31% -$39.8K ﹤0.01% 2806
2024
Q4
$134K Sell
4,217
-246
-6% -$7.73K ﹤0.01% 2630
2024
Q3
$129K Sell
4,463
-151
-3% -$4.95K ﹤0.01% 2599
2024
Q2
$177K Buy
4,614
+1,470
+47% +$82.8K ﹤0.01% 2510
2024
Q1
$279K Buy
+3,144
New +$204K ﹤0.01% 2372
2022
Q1
– Sell
-6,612
Closed -$3.19M – 2908
2021
Q4
$3.19M Buy
6,612
+2,576
+64% +$1.33M 0.01% 1527
2021
Q3
$2.09M Buy
+4,036
New +$1.78M ﹤0.01% 1808

Other funds holding SKIN

Russell Investments Group's SKIN Position: Q2 2026 in Review

Russell Investments Group reduced its SkinHealth Systems (SKIN) stake by 11% in Q2 2026, selling an estimated $5.4K and leaving 2,903 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3671.

Russell Investments Group first reported a position in SKIN in Q3 2021 and has held it in 12 quarters since. The position peaked at $3.19M in Q4 2021. 93 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Russell Investments Group held 2,903 shares of SkinHealth Systems worth $40.2K as of Q2 2026.
  • Russell Investments Group sold 353 SkinHealth Systems shares in Q2 2026, an estimated $5.4K.
  • SkinHealth Systems made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3671 holding.
  • Russell Investments Group first reported a position in SkinHealth Systems in Q3 2021 and has held it in 12 quarters since.
  • Russell Investments Group's SkinHealth Systems position peaked at $3.19M in Q4 2021.
  • 93 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.